In breast cancer, methyltransferase like 3 (METTL3), an m6A methyltransferase, accelerates pri-miR-221-3p maturation in an m6A-dependent manner, leading to adriamycin resistance in MCF-7 cells [38]. This evidence concerns the gene METTL3 and breast cancer.